Why Apply LT to an MS Population?
Patients with primarily spinal forms of MS clinically resemble individuals who have suffered an incomplete SCI in that both groups exhibit weakness in the extremities, spasticity, hyperreflexia, and loss of sensation, all of which can interfere with effective mobility. It is reasonable then to consider the application of therapeutic modalities that have been shown to benefit patients with SCI in terms of improving impairment and disability with respect to mobility to a selected MS population. The studies cited demonstrate the potential benefits of LT in the SCI population, but further randomized clinical trials are needed.
